Skip to content
Newsletter
Toggle navigation
Newsletter
Search for:
Search
About angioedema
Toggle menu
What is angioedema?
Types
Acquired angioedema
Hereditary angioedema
Idiopathic angioedema
Acute allergic angioedema
Drug-induced nonallergic angioedema
Causes
Diagnosis
Symptoms
Living with angioedema
Diet
Treatments
Toggle menu
Approved treatments
Experimental treatments
Featured topics
Toggle menu
Taking action with HAE
HAE and advocacy
Next steps after an HAE diagnosis
Beyond swelling: Other HAE symptoms
Treatment and management of HAE attacks
Raising a child with HAE
HAE triggers and prevention plan
HAE and preventive treatment
Bracing for a diagnosis
HAE and stress
Angioedema and skin care
View all
Navigating HAE
HAE pool prep
HAE journey
HAE genetics
HAE and factor XII
Managing HAE medications
HAE and women
Traveling with HAE
HAE awareness and advocacy
Talking to your doctor
Self-care tips for caregivers
View all
News
Columns
Toggle menu
Dancing with Rare Disease
— Natalie Sirota
From the Caregiver’s HAErt
— Danita LaShelle Jones
Living Rare, Speaking Loud
— Hollie Amadio
Search
Close drawer
What can we help you find today?
Search for:
Search
Search
Takeda, —
Articles by
Recent Posts
Study confirms Takhzyro’s long-term benefits for HAE patients
First-of-its-kind therapy Dawnzera wins FDA approval for HAE
Deucrictibant set for key trial in acquired angioedema
Even if we have common symptoms of HAE, each patient is unique
Sebetralstat gets to keep orphan drug status for HAE in Europe
Envelope icon
Subscribe to our newsletter
Get regular updates to your inbox.
Email Address
(Required)
LinkedIn
This field is for validation purposes and should be left unchanged.
Δ
